| Financial Year |
March 31 2023 |
| Monetary Funds |
168,507,663.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
38,227,375.00 |
| Accounts Receivable |
93,129,880.11 |
| Advances to Suppliers |
83,838,444.11 |
| Other Receivables |
58,780,990.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
238,329,381.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,782,369.25 |
| Total Current Assets |
732,331,494.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
72,004,449.15 |
| Investment Properties |
-- |
| Fixed Assetes |
1,018,289,108.61 |
| Under-construction Projects |
117,411,878.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,952,911.72 |
| R&D expenses |
8,171,601.40 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,566,658.35 |
| Deferred Income Tax Assets |
21,484,162.22 |
| Other Non-Current Assets |
261,399,069.30 |
| Sub-Total of Non-Current Assets |
1,680,817,175.87 |
| Total Assets |
2,413,148,670.61 |
| Short-Term Loans |
298,453,739.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
85,483,174.43 |
| Accounts Payable |
248,672,898.33 |
| Accounts Received In Advance |
1,200,116.52 |
| Employee Compensation Payable |
14,974,202.54 |
| Taxes Payable |
9,736,904.48 |
| Interest Payable |
-- |
| Dividend Payable |
190,968.37 |
| Other payables |
31,805,632.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
58,785,749.83 |
| Other Current Liabilities |
10,679,904.86 |
| Sub-Total of Current Liabilities |
841,945,437.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
31,213,434.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
67,627,884.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
133,910,953.99 |
| Total Liabilities |
975,856,391.03 |
| Paid-In Capital(Or Share Stock) |
609,182,254.00 |
| Capital Surplus |
94,082,993.00 |
| Surplus Reserve |
71,348,827.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
602,622,948.24 |
| Minority Stockholder's Interest |
27,128,124.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,410,164,155.19 |
| Owner's Equity（Stockholder's Equity） |
1,437,292,279.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,413,148,670.61 |
